David Gilman

David Gilman is a Partner at ClearView Healthcare Partners, a consulting firm serving the life science sector.5 He brings extensive experience and expertise to the healthcare industry, having spent the past 25 years working to assist clients with life science innovation strategies.13

Professional Background

David joined ClearView as a Partner in 2019.4 His work has encompassed a wide range of strategic areas, including:

• Portfolio management
• Drug development
• Investment strategies
• Transactional strategies
• Partnering strategies

While David has worked across various therapeutic areas, he has particularly focused on oncology, immunology, infectious disease, and rare and orphan segments.1

Previous Experience

Prior to joining ClearView, David's career included:

• Managing Director of The Frankel Group in NYC and Israel
• Managing Director and lead of Huron's Life Science Strategy team
• Global Head of Portfolio Management, Business Development & Licensing at Novartis Oncology1

Education and Additional Activities

David holds an A.B. with honors in East Asian History from the University of Chicago and an MBA from the University of Texas at Austin.1 Beyond his consulting work, he has:

• Taught life sciences to business students
• Taught business to medical students
• Published works on drug pricing, reimbursement, and innovation ecosystem economics1

David Gilman's LinkedIn profile confirms his current position at ClearView Healthcare Partners and his educational background at the University of Texas at Austin.2